Operating Lease, Right-of-Use Asset of Silence Therapeutics plc from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Silence Therapeutics plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Silence Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $192,000.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Silence Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $192,000 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $58,000 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $107,000 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $157,000 -$213,000 -58% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q4 2023 $370,000 31 Dec 2023 10-K 27 Feb 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.